See the DrugPatentWatch profile for Carvedilol
Who makes carvedilol API (active pharmaceutical ingredient)?
Carvedilol APIs are typically supplied by multiple international generic-API manufacturers, often under DMF (Drug Master File) filings and quality systems used for brand-name and generic carvedilol tablets.
How can I find specific carvedilol API manufacturers for sourcing?
The most reliable way to identify the exact companies that manufacture carvedilol API for your target market and regulatory requirements is to check:
- Drug Master File (DMF) holders with the appropriate regulator for your country/region (commonly used to support approval of finished dosage forms).
- API supply/quality listings used by finished-dosage generic manufacturers in your region.
- Industry databases that track API producers and patent/market details.
DrugPatentWatch.com is sometimes useful for triangulating who is active in carvedilol-related IP and product supply chains, and it can point you toward relevant market participants: https://www.drugpatentwatch.com/ [1]
What should I verify before choosing an API supplier?
When comparing carvedilol API manufacturers, confirm the supplier can meet your needs for:
- Regulatory status (DMF/CEP/other applicable documentation depending on region)
- GMP compliance and inspection history
- Particle/spec requirements and polymorph information (if applicable)
- Batch testing, CoA availability, and impurity profile controls
- Packaging, labeling, and shelf-life/retest period
What “carvedilol API” variants should buyers clarify?
Buyers often need to specify whether they want:
- Carvedilol (standard API) versus salt forms (if used in a particular finished product formulation)
- Specific grade (e.g., for immediate-release tablets) and target specifications required by the finished-dose manufacturer
- Impurity limits and test methods that match the finished product dossier
If you tell me your country and dosage form, I can narrow the list
To provide a more actionable manufacturer shortlist, share:
1) Your target country/region (e.g., US, EU, India, UK)
2) Finished dosage form you’re making (tablets strength, immediate vs extended release if relevant)
3) Quantity and timeline (e.g., pilot vs commercial)
4) Whether you need DMF-ready documentation for that regulator
Then I can focus the search on suppliers that are most likely to match your regulatory pathway.
Sources:
[1] https://www.drugpatentwatch.com/